header image

Careers and Jobs


Laboratory of Dr. Kathy Shair

UPMC Hillman Cancer Center Cancer Virology Program

Post date: October 10, 2018

Position: Full time, immediate start date

Experience: Entry-level to 2 years post-doc preferredEpstein-Barr virus-associated cancersA postdoctoral position is immediately available to identify biomarkers for Epstein-Barr virus (EBV)-associated cancers. The ideal candidate should have a Ph.D inthe field of virology or cancer biology. The project is lab-based and translational.The incumbent will participate in a 2-year epidemiology project using humanbiospecimens. Opportunities exist to work with tissue culture and molecularvirology techniques. Experience in standard molecular biology and protein analysisis required, but candidates with independent thinking, experimental rigor andevidence of scientific writing and presentation will be the most highly ranked.The Shair lab investigates EBV mechanisms of oncogenesis. Current projects in the Shair lab include: 1) oncogenic signaling mechanisms of EBV latent membraneproteins (LMP) 1 and LMP2A, 2) determinants of EBV latency and persistence inepithelial cancers, and 3) identifying biomarkers for EBV-associated cancers. The Shair lab at the University of Pittsburgh is housed in the Cancer Virology Program, Hillman Cancer Center, where our common interest is to elucidate the molecularbasis of cancer and translational medicine.

To be considered, please submit a C.V. and names of 3 references to Dr. Shair (kas361@pitt.edu). Applicants will be continually reviewed until the position is filled. In the cover letter, please also indicate your nationality and eligibility for NIH funded postdoc training grants.

“The University of Pittsburgh is an Equal Employment Opportunity/Affirmative Action/Males/Females/Veterans/Disabled”


Postdoctoral Positions in the lab of Dr. Gary Thomas - Start date - March 1, 2019

An NIH-funded postdoctoral position is available for a highly motivated individual to study the regulation of Sirt1 activity in liver by a newly discovered family of protein modulators (see Krzysiak et al., Mol Cell, 2018 (in press)). Successful candidates will have a strong background in molecular biology methods and animal models of disease. Experience in enzyme biochemistry, RNA-Seq and seahorse measurements is highly desirable.

A postdoctoral position is available for a highly motivated individual to study PACS1 and PACS2 neurodevelopmental diseases (see Olson et al Amer. J. Human Genet 102:995 (2018)). Successful candidates are expected to have a strong background in molecular and cellular neurobiology, including IPSC methods, and will collaborate with researchers studying these neurologic disorders from the atom to the whole-organism level.

c/o Dr. Gary Thomas Department of Microbiology and Molecular Genetics University of Pittsburgh School of Medicine Suite 507, 450 Technology Dr. Pittsburgh, PA 15219